Analog Devices, Inc.(Nasdaq:ADI)today announced it will release financial results for the fourth quarter fiscal year 2025 at7:00 a.m. Eastern timeonTuesday, November 25, 2025. Following the press release, the Company will host a conference call at10:00 a.m. Eastern time, the same day.Vincent Roche, Chief Executive Officer and Chair,Richard Puccio, Executive Vice President and Chief Financial Officer, […]

X4 Pharmaceuticals Announces Proposed Underwritten Public Offering GlobeNewswire October 23, 2025 BOSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR) (“X4” or the “Company”), a company driven to improve the lives of people with rare hematology diseases, today announced that it has commenced an underwritten public offering of shares of its common stock

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules GlobeNewswire October 23, 2025 Financing led by Samsara BioCapital, L.P. (“Samsara”) with participation from additional investors, including RA Capital Management, Anomaly, Special Situations Funds, Invus and Mr. Mir Imran Each of Samsara and Anomaly has the right to designate one

Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 GlobeNewswire October 23, 2025 CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its third quarter 2025 financial results after market close on Thursday,

Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025 GlobeNewswire October 23, 2025 LONDON, Oct. 23, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 28, 2025 at 8:30 a.m. Eastern Time to report its

Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors GlobeNewswire October 23, 2025 Mechelen, Belgium; October 23, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new in vitro pharmacological data from its selective TYK2 inhibitor, GLPG3667, currently in two

Waterstone Financial, Inc. Announces Results of Operations for the Quarter and Nine Months Ended September 30, 2025 GlobeNewswire October 23, 2025 WAUWATOSA, Wis., Oct. 23, 2025 (GLOBE NEWSWIRE) — Waterstone Financial, Inc. (NASDAQ: WSBF), holding company for WaterStone Bank, reported net income of $7.9 million, or $0.45 per diluted share, for the quarter ended September

Ziegler is pleased to announce the successful closing of Shenandoah Valley Westminster-Canterbury's $16,469,896 Series 2025 Bonds. https://mma.prnewswire.com/media/2757205/Ziegler_CIA_Logo_Logo_Logo.jpg Shenandoah Valley Westminster-Canterbury (SVWC) is a Virginia not-for-profit organization that owns and operates a life plan community located in Winchester, Virginia. SVWC was founded in 1982 and provides housing, health care, and other services on its 87-acre campus

CIBC Asset Management Inc. (“CAMI”), has filed an early warning report on SEDAR+ (www.sedarplus.com) with respect to the common shares (the “Shares”) of Trisura Group Ltd (the “Issuer”), to disclose historical acquisitions by CAMI of Shares of the Issuer on behalf of its managed investment funds and client accounts over which is has discretionary authority.

(NasdaqGM:ALISU),(NasdaqGM:ALIS),(NasdaqGM:ALISR), NEW YORK, NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) — Calisa Acquisition Corp (the “Company”) announced today that it consummates its initial public offering of 6,000,000 units at $10.00 per unit. The offering resulted in gross proceeds to the Company of $60,000,000. The Company's units are listed on the Global Market tier of The